Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus. 2010

Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
Department of Anatomy and Cell Biology, College of Veterinary Medicine and BK21 Program for Veterinary Science, Seoul National University, Seoul, 151-742, South Korea.

In this study, we observed the effects of lipopolysaccharide (LPS) on neurodegeneration and immune response in the hippocampus. LPS is a gram-negative bacterial cell surface proteoglycan and known as a bacterial endotoxin. For this, we investigated the optimal concentration of LPS influencing the ICR mouse hippocampus to measure the LPS receptor, e.g., toll-like receptor 4 (TLR4), expression in mouse hippocampal homogenates. TLR4 expression was significantly and prominently increased in the hippocampal homogenates of the LPS (1 mg/kg)-treated group. Next, we examined pro-inflammatory response in the hippocampus using cyclooxygenase-2 (COX-2, a marker for inflammatory response) immunohistochemistry after LPS treatment. COX-2 immunoreactivity was significantly increased in the endothelium of blood vessels in the hippocampus 6 h after LPS treatment, judging from double immunofluorescence study with platelet-derived endothelial cell adhesion molecule-1 (PECAM-1, a marker for endothelial cells): it decreased 12 h and disappeared 24 h after LPS treatment. In addition, the ionized calcium-binding adapter molecule 1 (Iba-1)-immunoreactive ((+)) microglia were morphologically activated in the mouse hippocampus after LPS treatment. At 24 h after LPS treatment, Iba-1(+) microglia of activated forms were abundant in the hippocampus. However, NeuN (a neuron-specific soluble nuclear antigen)(+) neurons were not significantly changed in the hippocampus after LPS treatment. Fluoro-jade B (a marker for neuronal degeneration)(+) cells were not detected in the hippocampus at any time after LPS treatment. In addition, there were no significant differences in permeability of blood-brain barriers at any time points after LPS treatment. In brief, our results indicate that intraperitoneal administration of 1 mg/kg LPS effectively induces LPS receptor (TLR4) expression in the hippocampus, and the treatment increases corticosterone levels, inflammation in the blood vessels, and microglial activation in the hippocampus without any neuronal damage.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008840 Microfilament Proteins Monomeric subunits of primarily globular ACTIN and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell. Actin Binding Protein,Actin-Binding Protein,Actin-Binding Proteins,Microfilament Protein,Actin Binding Proteins,Binding Protein, Actin,Protein, Actin Binding,Protein, Actin-Binding,Protein, Microfilament,Proteins, Actin-Binding,Proteins, Microfilament
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins

Related Publications

Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
May 1997, The Journal of comparative neurology,
Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
October 2010, Brain research,
Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
March 1996, Brain research,
Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
January 2023, In vivo (Athens, Greece),
Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
June 2013, The journal of ECT,
Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
December 2009, Behavioural brain research,
Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
February 2009, Cardiovascular research,
Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
January 2010, Neurochemical research,
Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
August 2015, Fundamental & clinical pharmacology,
Dae Won Chung, and Ki-Yeon Yoo, and In Koo Hwang, and Dae Won Kim, and Jin Young Chung, and Choong Hyun Lee, and Jung Hoon Choi, and Soo Young Choi, and Hwa Young Youn, and In Se Lee, and Moo-Ho Won
December 2021, Journal of neuroimmunology,
Copied contents to your clipboard!